tiprankstipranks
Trending News
More News >
Invex Therapeutics Ltd. (AU:IXC)
ASX:IXC
Australian Market

Invex Therapeutics Ltd. (IXC) Financial Statements

Compare
2 Followers

Invex Therapeutics Ltd. Financial Overview

Invex Therapeutics Ltd.'s market cap is currently AU$8.27M. The company's EPS TTM is AU$-0.002; its P/E ratio is -19.05; Invex Therapeutics Ltd. is scheduled to report earnings on August 10, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueAU$ 229.08KAU$ 1.21MAU$ 459.08KAU$ 182.25KAU$ 0.00
Gross ProfitAU$ 229.08KAU$ 1.21MAU$ 459.08KAU$ 182.25KAU$ 0.00
Operating IncomeAU$ -709.30KAU$ -2.13MAU$ -8.55MAU$ -4.03MAU$ -2.44M
EBITDAAU$ 0.00AU$ -720.00KAU$ -8.21MAU$ -4.14MAU$ -2.28M
Net IncomeAU$ -476.87KAU$ -1.64MAU$ -7.75MAU$ -3.95MAU$ -2.28M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 5.38MAU$ 6.03MAU$ 22.47MAU$ 29.34MAU$ 32.72M
Total AssetsAU$ 5.47MAU$ 6.12MAU$ 22.80MAU$ 29.49MAU$ 32.74M
Total DebtAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Net DebtAU$ -5.38MAU$ -6.03MAU$ -22.47MAU$ -29.34MAU$ -32.72M
Total LiabilitiesAU$ 220.59KAU$ 431.63KAU$ 1.57MAU$ 1.00MAU$ 658.61K
Stockholders' EquityAU$ 5.25MAU$ 5.69MAU$ 21.23MAU$ 28.48MAU$ 32.08M
Cash Flow
Free Cash FlowAU$ -652.57KAU$ -2.44MAU$ -6.87MAU$ -3.38MAU$ -1.68M
Operating Cash FlowAU$ -652.57KAU$ -2.44MAU$ -6.87MAU$ -3.38MAU$ -1.68M
Investing Cash FlowAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Financing Cash FlowAU$ 0.00AU$ -14.00MAU$ 0.00AU$ 0.00AU$ 8.09M
Currency in AUD

Invex Therapeutics Ltd. Earnings and Revenue History

Invex Therapeutics Ltd. Debt to Assets

Invex Therapeutics Ltd. Cash Flow

Invex Therapeutics Ltd. Forecast EPS vs Actual EPS